
|Articles|February 4, 2022
AJMC® in the Press, February 4, 2022
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
An article by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
2
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
3
AMCP Nexus Bringing the Latest on Health Policy, Drug Access, and Value-Based Care
4
Low Trial Enrollment, Racial Disparities Limit Breast Cancer Treatment Innovation
5















































